上尿路结石腔内碎石术后尿源性脓毒血症的护理体会

摘要
图/表
参考文献
相关文章 (15)

[1]	Srirangam S J,Darling R,Stopford M, et al.Contemporary practice of percutaneous nephrolithotomy: review of practice in a single region of the UK[J].Ann R Coll Surg Engl ,2008,90(1):40-44.
[2]	黄浩夫,湛海伦,刘小彭,等.尿源性脓毒血症的防治[J].中华临床医师杂志,2012,6(7):164-166.
[3]	申吉泓,张白羽.泌尿外科医师必须高度重视的尿源性脓毒血症[J].现代泌尿外科杂志,2014,19(4):219-221.
[4]	Grabe M, Bartoletti R, Bjeklund-Johansen T E, et al. Guidelines on Urological Infections [M]. European Association of Urology, 2015:26-31.
[5]	邓刚,马立彬,居翔,等. 血清降钙素原在上尿路腔内碎石术后脓毒血症诊治中的应用研究[J]. 中华医院感染学杂志, 2013,24(23):5924-5926.
[6]	佟爱华,董梅,孙敏霞,等.泌尿系感染的病原菌分布及耐药性调查[J].武警医学, 2012,23(4):321-326.
[7]	Gaieski D F, Edwards J M, Kallan M J, et al. Benchmarking the incidence and mortality of severe sepsis in the United States[J]. Crit Care Med, 2013,41(5):1167-1174.
[8]	Kumar A, Roberts D, Wood K E, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006,34(6):1589-1596.
[9]	Liu H H, Guo J B, Geng Y, et al. Procalcitonin: present and future [J]. Ir J Med Sci,2015,184(3):597-605.
[10]	Miroslav Prucha, Geoff Bellingan , Roman Zazula .Sepsis biomarkers[J]. Clinica Chimica Acta,2015,440: 97-103.
[11]	Rowland T, Hilliard H, Barlow G. Procalcitonin: potential role in diagnosis and management of sepsis [J]. Adv Clin Chem,2015,68:71-86.
[12]	Ronco C. Endotoxin removal: history of a mission[J]. Blood Purif, 2014, 37, 1 : 5-8.
[13]	Su W, Ding X. Methods of Endotoxin Detection[J]. J Lab Autom, 2015, 20 (4) : 354-364.